Skip to content

Colour Doppler Flow Imaging in Lacrimal Gland Lesions

Usefulness of Colour Doppler Flow Imaging in the Management of Lacrimal Gland Lesions

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02900846
Acronym
GLIR
Enrollment
51
Registered
2016-09-14
Start date
2003-01-31
Completion date
2016-08-31
Last updated
2017-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lacrimal Tumor

Brief summary

Retrospective medical charts and medical imaging files review of patients suffering from lacrimal fossa lesions who underwent ocular ultrasonography with color flow doppler imaging.

Interventions

None listed

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
Lead SponsorNETWORK

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients suffering from lacrimal fossa tumor * Orbital ultrasonography performed, including doppler flow imaging * Histopathological characterization of the tumor obtained after surgical removal

Exclusion criteria

* Absence of histopathological characterization * Absence of documented ultrasound doppler flow imaging

Design outcomes

Primary

MeasureTime frame
Pulsed wave doppler resistance index in tumor vascularization1 week

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026